BIOMAT Database Logo BIOMAT Database Logo

Synthesis and anti-HIV activity of [AZT]-[TSAO-T] and [AZT]-[HEPT] dimers as potential multifunctional inhibitors of HIV-1 reverse transcriptase. 1995

S Velázquez, and R Alvarez, and A San-Félix, and M L Jimeno, and E De Clercq, and J Balzarini, and M J Camarasa
Instituto de Química Médica (CSIC), Juan de la Cierva, Madrid, Spain.

In an attempt to combine the HIV-inhibitory capacity of 2',3'-dideoxynucleoside (ddN) analogues and non-nucleoside reverse transcriptase (RT) inhibitors (NNRTI), we have designed, synthesized, and evaluated for their anti-HIV activity several dimers of the general formula [ddN]-(CH2)n-[NNRTI]. These dimers combine in their structure a ddN such as AZT and a NNRTI such as TSAO-T and HEPT linked through an appropriate spacer between the N-3 of the thymine base of both compounds. The [TSAO-T]-(CH2)n-[AZT] dimers proved markedly inhibitory to HIV-1. Also, if AZT was replaced by thymidine in the dimer molecules, potent anti-HIV-1 activity was observed. However, although the compounds proved inhibitory to HIV-1, they were less potent inhibitors than the parent compounds from which they were derived. None of the dimers were endowed with anti-HIV-2 activity. In contrast with the TSAO-T monomers, none of the TSAO-T-containing dimers proved markedly cytotoxic to the cells. There was a clear trend toward decreased antiviral potency with lengthening the methylene spacer in the [TSAO-T]-(CH2)n-[AZT] dimers.

UI MeSH Term Description Entries
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013141 Spiro Compounds Cyclic compounds that include two rings which share a single atom (usually a carbon). The simplest example of this type of compound is Spiro[2.2]pentane, which looks like a bow tie. Compounds, Spiro
D013936 Thymidine A nucleoside in which THYMINE is linked to DEOXYRIBOSE. 2'-Deoxythymidine,Deoxythymidine,2' Deoxythymidine
D013941 Thymine One of four constituent bases of DNA. 5-Methyluracil,5 Methyluracil
D014529 Uridine A ribonucleoside in which RIBOSE is linked to URACIL. Allo-Uridine,Allouridine,Allo Uridine
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

S Velázquez, and R Alvarez, and A San-Félix, and M L Jimeno, and E De Clercq, and J Balzarini, and M J Camarasa
Synthesis and evaluation of "AZT-HEPT", "AZT-pyridinone", and "ddC-HEPT" conjugates as inhibitors of HIV reverse transcriptase.
May 2000, Journal of medicinal chemistry,
S Velázquez, and R Alvarez, and A San-Félix, and M L Jimeno, and E De Clercq, and J Balzarini, and M J Camarasa
Potential multifunctional inhibitors of HIV-1 reverse transcriptase. Novel [AZT]-[TSAO-T] and [d4T]-[TSAO-T] heterodimers modified in the linker and in the dideoxynucleoside region.
December 1999, Journal of medicinal chemistry,
S Velázquez, and R Alvarez, and A San-Félix, and M L Jimeno, and E De Clercq, and J Balzarini, and M J Camarasa
Nonnucleoside HIV-1 reverse-transcriptase inhibitors, part 5. Synthesis and anti-HIV-1 activity of novel 6-naphthylthio HEPT analogues.
August 2005, Chemical & pharmaceutical bulletin,
S Velázquez, and R Alvarez, and A San-Félix, and M L Jimeno, and E De Clercq, and J Balzarini, and M J Camarasa
TSAO derivatives, inhibitors of HIV-1 reverse transcriptase dimerization: recent progress.
January 2006, Current pharmaceutical design,
S Velázquez, and R Alvarez, and A San-Félix, and M L Jimeno, and E De Clercq, and J Balzarini, and M J Camarasa
Synthesis of 5-alkynylated d4T analogues as potential HIV-1 reverse transcriptase inhibitors.
December 2004, Journal of enzyme inhibition and medicinal chemistry,
S Velázquez, and R Alvarez, and A San-Félix, and M L Jimeno, and E De Clercq, and J Balzarini, and M J Camarasa
Synthesis and evaluation of 3-hydroxy-3-phenylpropanoate ester–AZT conjugates as potential dual-action HIV-1 Integrase and Reverse Transcriptase inhibitors.
December 2015, Bioorganic & medicinal chemistry,
S Velázquez, and R Alvarez, and A San-Félix, and M L Jimeno, and E De Clercq, and J Balzarini, and M J Camarasa
Nonnucleoside HIV-1 reverse transcriptase inhibitors: Part I. Synthesis and structure-activity relationship of 1-alkoxymethyl-5-alkyl-6-naphthylmethyl uracils as HEPT analogues.
July 2003, Chemical & pharmaceutical bulletin,
S Velázquez, and R Alvarez, and A San-Félix, and M L Jimeno, and E De Clercq, and J Balzarini, and M J Camarasa
[Reverse transcriptase inhibitors as anti-HIV agents].
September 1993, Nihon rinsho. Japanese journal of clinical medicine,
S Velázquez, and R Alvarez, and A San-Félix, and M L Jimeno, and E De Clercq, and J Balzarini, and M J Camarasa
An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
September 1998, Antiviral chemistry & chemotherapy,
S Velázquez, and R Alvarez, and A San-Félix, and M L Jimeno, and E De Clercq, and J Balzarini, and M J Camarasa
Synthesis and evaluation of quinoxalinones as HIV-1 reverse transcriptase inhibitors.
August 2000, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!